iTeos Therapeutics, Inc.
ITOS · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$78,728 | -$34,613 | -$43,712 | -$45,358 |
| Dep. & Amort. | $340 | $324 | $324 | $302 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $5,881 | $6,635 | $7,073 | $7,543 |
| Change in WC | $32,689 | -$6,878 | $48,401 | $31,390 |
| Other Non-Cash | -$2,628 | $768 | -$6,589 | -$31,228 |
| Operating Cash Flow | -$42,446 | -$33,764 | $5,497 | -$37,351 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$283 | -$101 | -$152 | -$94 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$29,647 | -$60,344 | -$80,205 | -$195,523 |
| Inv. Sales/Matur. | $116,886 | $108,161 | $93,999 | $104,127 |
| Other Inv. Act. | -$2 | -$24 | -$25 | $0 |
| Investing Cash Flow | $86,954 | $47,692 | $13,617 | -$91,490 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $32 | $274 | -$231 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $4,493 | $0 | $11 | -$211 |
| Financing Cash Flow | $4,493 | $32 | $285 | -$442 |
| Forex Effect | $2,289 | $459 | -$1,022 | $1,935 |
| Net Chg. in Cash | $51,290 | $14,419 | $18,377 | -$127,045 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $156,849 | $142,430 | $124,053 | $251,098 |
| End Cash | $208,139 | $156,849 | $142,430 | $124,053 |
| Free Cash Flow | -$42,729 | -$33,865 | $5,345 | -$37,445 |